Skip to main content
Colleen Annesley, MD, Pediatric Hematology & Oncology, Seattle, WA

Colleen Elizabeth Annesley MD


Assistant Professor, Seattle Children's Hospital, University of Washington

Join to View Full Profile
  • 4800 Sand Point Way NECancer and Blood Disorders Center, Seattle Children's HospitalSeattle, WA 98145

  • Phone+1 206-987-7122

  • Fax+1 206-987-3946

Dr. Annesley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Pediatrics, 2006 - 2009
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2006

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2015 - 2026
  • MD State Medical License
    MD State Medical License 2009 - 2016
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Beyond the Storm — Subacute Toxicities and Late Effects in Children Receiving CAR T Cells
    Beyond the Storm — Subacute Toxicities and Late Effects in Children Receiving CAR T CellsJanuary 25th, 2021
  • Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood Cancers
    Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 5th, 2021
  • 22-Year-Old College Student Beats Leukemia, Returns to School After Successful Cancer Treatment for Young Adults at Seattle Children’s
    22-Year-Old College Student Beats Leukemia, Returns to School After Successful Cancer Treatment for Young Adults at Seattle Children’sJuly 13th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: